Pathstone Holdings’s Hims & Hers Health HIMS Stock Holding History

Pathstone Holdings’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.45M	Buy	70,526 +1,067	+2%	+$28.6K	0.01%	994
2026 Q1	$1.44M	Buy	69,459 +985	+1%	+$23.3K	0.01%	1217
2025 Q4	$2.22M	Sell	68,474 -22,266	-25%	-$954K	0.01%	962
2025 Q3	$5.15M	Buy	90,740 +32,737	+56%	+$1.68M	0.02%	552
2025 Q2	$2.89M	Buy	58,003 +6,451	+13%	+$292K	0.01%	787
2025 Q1	$1.52M	Sell	51,552 -7,011	-12%	-$260K	0.01%	1139
2024 Q4	$1.42M	Sell	58,563 -9,794	-14%	-$243K	0.01%	1172
2024 Q3	$1.26M	Sell	68,357 -250	-0.4%	-$4.48K	0.01%	1245
2024 Q2	$1.39M	Sell	68,607 -21,412	-24%	-$356K	0.01%	1121
2024 Q1	$1.39M	Buy	90,019 +24,734	+38%	+$279K	0.01%	1082
2023 Q4	$581K	Buy	+65,285	New	+$483K	﹤0.01%	1407

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Pathstone Holdings's HIMS Position: Q2 2026 in Review

Pathstone Holdings increased its Hims & Hers Health (HIMS) stake by 1.5% in Q2 2026, buying an estimated $28.6K and bringing the position to 70,526 shares worth $2.45M. The position accounts for 0.01% of the portfolio, ranked #994.

Pathstone Holdings first reported a position in HIMS in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.15M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Pathstone Holdings held 70,526 shares of Hims & Hers Health worth $2.45M as of Q2 2026.
Pathstone Holdings bought 1,067 Hims & Hers Health shares in Q2 2026, an estimated $28.6K.
Hims & Hers Health made up 0.01% of Pathstone Holdings's portfolio in Q2 2026, its #994 holding.
Pathstone Holdings first reported a position in Hims & Hers Health in Q4 2023 and has held it in 11 quarters since.
Pathstone Holdings's Hims & Hers Health position peaked at $5.15M in Q3 2025.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.